Elizabeth Tolley, PhDScientist, Social and Behavioral Health Sciences
Areas of expertise
- HIV prevention research
- HIV in adolescents
Projects & Resources
Should ongoing clinical trials identify an effective microbicide, the next challenge will be to ensure product access and use. Communication campaigns will play a critical role in generating demand and encouraging correct use.
FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.